Bexarotene is a retinoid compound with high specificity for retinoid X receptors (RXRs). It is approved as a chemotherapeutic for the treatment of cutaneous T-cell lymphoma and has also been investigated for its potential therapeutic role in Alzheimer’s disease.
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
